# Nuclide record eclipse-psma (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/eclipse-psma/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "eclipse-psma", "NCT05204927" ;
  schema:name "ECLIPSE"@en ;
  schema:description "Curium's PSMA radioligand met its progression endpoint; survival data and an FDA filing are pending."@en ;
  schema:url <https://nuclide.cc/trials/eclipse-psma/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05204927> ;
  nuclide:status "positive" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-mcrpc/> ;
  nuclide:drugs <https://nuclide.cc/drugs/lu177-psma-it/> .